The bill aims to amend the definition of "drug paraphernalia" in Florida law by excluding certain narcotic-drug-testing products, such as test strips and reagent kits, from this classification. The legislative findings highlight the ongoing crisis of deaths related to synthetic opioids and other dangerous substances, emphasizing the need for harm reduction strategies. The intent of the Legislature is to decriminalize the possession, distribution, and use of these drug-testing products, allowing residents to access critical information about the presence of harmful substances, thereby preventing overdose and fatalities.

Specifically, the bill revises Section 893.145 of the Florida Statutes to clarify that drug paraphernalia does not include testing products used solely to determine the presence of fentanyl, fentanyl analogues, or other controlled substances and adulterants. This change is intended to facilitate harm reduction efforts by ensuring that individuals can utilize these testing products without fear of legal repercussions. The act is set to take effect on July 1, 2026.

Statutes affected:
H 477 Filed: 893.145